-
-
-
-
-
-
News
-
-
Contact UsThe company focuses on the research, development, production, and sales of chemical raw materials and their formulations. All products have passed national GMP certification, and core products have successively passed official pharmaceutical regulatory certifications from multiple countries, including the EU EDQM, US FDA, Japanese PMDA, and South Korean MFDS. Following its successful listing on the Shenzhen Stock Exchange's ChiNext board on April 4, 2023, Keyuan Pharmaceutical has entered a phase of rapid development driven by both digital intelligence and capital, with its business spanning dozens of countries and regions worldwide.
Medical beauty material CMO/CDMO business
Koyuan Pharmaceutical has upgraded its medical aesthetics materials CMO/CDMO business unit, dedicated to providing global medical aesthetics industry clients with full-process solutions from R&D to commercial production.
|
Leveraging the Group's years of accumulated technology and international quality management system in the biopharmaceutical field, we focus on the innovative development and efficient production of medical aesthetics materials. |
Based on profound R&D accumulation in core medical aesthetics raw materials such as full molecular weight PLLA/PCL, mPEG-PCL, and DHHB, we have built a full-chain technology system from raw material synthesis, formulation design to terminal product development. |
Relying on our self-developed innovative process platform, we continuously optimize key technologies such as microsphere particle size control, sustained-release performance improvement, and stability enhancement to meet the high-end needs of medical aesthetics products in scenarios such as long-term shaping, skin regeneration, and photoprotection.
To ensure product quality and global market access, Koyuan Pharmaceutical has built advanced production lines that meet international standards, equipped with intelligent production equipment and a digital management system, and has repeatedly passed international authoritative certification audits such as FDA, EU CE, and ISO13485. The company strictly follows GMP standards, implementing full life-cycle quality management from raw material traceability, process parameter monitoring to finished product testing, ensuring the high purity, low allergenicity, and batch consistency of each batch of products.
Through R&D innovation + International certification + Flexible intelligent manufacturing integrated service model, Koyuan Pharmaceutical is committed to providing global customers with compliant, efficient, and customized medical aesthetics material solutions, empowering partners to break through technological barriers and quickly seize market opportunities.
Address: No. 26, Keyuan Street, Shanghe County, Jinan City, Shandong Province
Free Service Hotline